In contrast, TIM-3 is only marginally increased on NK cells to oppose NK cell activation.152 Therefore, further research should better determine the role of TIM-3 in tumor surveillance to better understand its potential application in NK cell-mediated cancer treatment. The gene discussed is HAVCR2; the disease is neoplasm.